Agility LP Ankle Arthroplasty Outcomes

NCT ID: NCT01366872

Last Updated: 2012-12-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a research study which is being done to determine the outcomes following Agility LP ankle replacement. This implant was approved by the FDA in 2007 and has been used since then with good early results. You are being asked to volunteer for this study because you have undergone Total Ankle Arthroplasty with Agility LP prosthesis. The purpose of the study is to compare the range of motion, level of pain and function during daily living prior to and after your ankle surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis of Ankle Osteoarthritis of Ankle Traumatic Arthritis of Ankle

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

ankle arthritis total ankle arthroplasty Agility LP,

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years old
* Can comprehend and sign the informed consent
* Patient must have undergone Agility LP ankle replacement between January 2006 to June 2008

Exclusion Criteria

* Patient has had following procedures on the study limb within two years of TAA
* Revision of TAA
* Ankle arthrodesis
* Amputation
* Agility LP arthroplasty was done as a revision procedure for a failed TAA or as a takedown of ankle fusion.
* Any condition that, in the opinion of the investigator, makes the patient unsuitable for participation in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Orthopaedic Associates of Michigan, PC

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John G. Anderson, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John G Anderson, MD

Role: PRINCIPAL_INVESTIGATOR

Orthopaedic Associates of Michigan, PC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Orthopaedic Associates of Michigan, PC

Grand Rapids, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OAM-LP-2010

Identifier Type: -

Identifier Source: org_study_id